As an Associate Principal Scientist/Associate Director, In Vivo Pharmacology, you will be leading research to evaluate the efficacy and mechanisms of action of small molecules in hematology-oncology
Job Summary
As an Associate Principal Scientist/Associate Director, In Vivo Pharmacology, you will be leading research to evaluate the efficacy and mechanisms of action of small molecules in hematology-oncology.
You will be responsible for leading a cross-functional working group focused on development and optimization of heme in vivo models in addition to biomarker assays for analysis of in vivo samples.
Our Waltham, Massachusetts facility develops life changing small-molecule research in North America, with innovative laboratories at the Gatehouse Park BioHub, just west of the city center.
Matching Summary
As an Associate Principal Scientist/Associate Director, In Vivo Pharmacology, you will be leading research to evaluate the efficacy and mechanisms of action of small molecules in hematology-oncology.
Salary
Base: $134,892.80 - $202,339.20 USD; Bonus/Equity: short-term incentive bonus opportunity, equity-based long-term incentive program; Benefits: qualified retirement program [401(k) plan], paid vacation and holidays, paid leaves, health benefits
Skills & Requirements
Must-have
hematology-oncology in vivo models
small-molecule drug discovery
in vivo and in vitro experiments
mechanism of action studies
oncology drug discovery process
cross-functional team collaboration
Nice-to-have
passion for research field
thought leadership
external key opinion leader engagement
innovative laboratories
activity-based work spaces
Key Requirements
Bachelor of Science with more than 7 years of research experience
Proven ability to lead multiple programs
Strong in vivo strategy and execution
Hands-on experience establishing hematologic oncology in vivo models
Track record delivering high-quality in vivo pharmacology data packages
Experience managing outsourced in vivo studies
Proven ability to create, submit, and manage IACUC protocols
Subject-matter expertise in myeloma, lymphoma, and acute myeloid leukemia biology